Axsome Therapeutics, Inc. (0HKF.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 9.06B |
| Enterprise Value | 8.98B |
| P/E Ratio | -66.45 |
| PEG Ratio | -1.48 |
| Price/Sales Ratio | 18.01 |
| Price/Book Ratio | 232.46 |
| Enterprise/Revenue | 17.89 |
| Enterprise/EBITDA | -73.35 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.27 |
| Operating Margin | -0.25 |
AD
Management Effectiveness
| Return On Assets | -0.26 |
| Return On Equity | -2.6 |
Income Statement
| Revenue | 638.5M |
| Revenue/Share | 13.83 |
| Gross Profit | 591.02M |
| EBITDA | -160.17M |
| Net Income | -183.17M |
| Diluted EPS | -3.68 |
Balance Sheet
| Total Cash | 305.11M |
| Total Cash/Share | 5.96 |
| Total Debt | 219.9M |
| Total Debt/Equity | 4.03 |
| Current Ratio | 1.39 |
| Book Value Per Share | 1.07 |
Price History
| 52-Week Change | 148.93 |
| 52-Week High | 255 |
| 52-Week Low | 55.64 |
| Moving Average 50 Days | 85.35 |
| Moving Average 200 Days | 75.3 |
Statistics
| Average Volume | 562 |
| Shares Outstanding | 50.33M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
